ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 85 filers reported holding ALLOVIR INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,968 | -33.8% | 36,264 | +4.8% | 0.00% | – |
| Q2 2023 | $117,689 | +82.9% | 34,614 | +112.0% | 0.00% | – |
| Q1 2023 | $64,329 | -20.1% | 16,327 | +4.0% | 0.00% | – |
| Q4 2022 | $80,505 | -29.4% | 15,693 | +8.0% | 0.00% | – |
| Q3 2022 | $114,000 | +128.0% | 14,535 | +12.4% | 0.00% | – |
| Q2 2022 | $50,000 | -41.2% | 12,927 | +2.8% | 0.00% | – |
| Q1 2022 | $85,000 | -47.2% | 12,580 | +1.0% | 0.00% | – |
| Q4 2021 | $161,000 | -48.4% | 12,454 | 0.0% | 0.00% | – |
| Q3 2021 | $312,000 | +191.6% | 12,454 | +129.4% | 0.00% | – |
| Q2 2021 | $107,000 | +18.9% | 5,429 | +41.5% | 0.00% | – |
| Q1 2021 | $90,000 | -15.1% | 3,838 | +38.2% | 0.00% | – |
| Q4 2020 | $106,000 | +92.7% | 2,777 | +37.8% | 0.00% | – |
| Q3 2020 | $55,000 | – | 2,015 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $28,611 | 1.60% |
| GMT CAPITAL CORP | 2,758,846 | $14,152,880 | 0.65% |
| SVB FINANCIAL GROUP | 43,019 | $220,687 | 0.60% |
| Regency Capital Management Inc.\DE | 75,025 | $384,878 | 0.44% |
| Redmile Group, LLC | 1,907,969 | $9,787,881 | 0.40% |
| Samsara BioCapital, LLC | 82,336 | $422,384 | 0.09% |
| Alkeon Capital Management | 4,605,104 | $23,624,184 | 0.09% |
| Woodline Partners LP | 1,087,090 | $5,576,772 | 0.08% |
| XTX Topco Ltd | 53,422 | $274,055 | 0.06% |
| Virtus ETF Advisers LLC | 20,906 | $107,248 | 0.06% |